A Phase Ib/II Study of CYT997 in Combination With Carboplatin in Relapsed Glioblastoma Multiforme.
Phase of Trial: Phase I/II
Latest Information Update: 02 Sep 2014
At a glance
- Drugs Lexibulin (Primary) ; Carboplatin
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Gilead Sciences
- 23 Sep 2011 Status changed from active, no longer recruiting to completed, as reported in a YM BioSciences media release.
- 23 Sep 2011 Interim results to be reported in the first half of 2012, according to a YM BioSciences media release.
- 21 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.